Wu Sijia, Zhang Zeyan, Yuan Wei, Yang Jing, Huang Xin
Department of Oral and Maxillofacial & Head and Neck Oncology, Beijing Stomatological Hospital, Capital Medical University, Beijing, China.
School of Rehabilitation, Capital Medical University, Beijing, China.
BMC Oral Health. 2025 Sep 29;25(1):1479. doi: 10.1186/s12903-025-06839-w.
This study aims to examine the temporal Trends in the burden of lip and oral cavity cancer in China from 1990 to 2021, stratified by age and sex. Key indicators-including prevalence, incidence, mortality, and disability-adjusted life years (DALYs)-are analyzed and compared with corresponding global metrics.
Using data from the Global Burden of Disease (GBD) database spanning 1990 to 2021, we conducted a systematic analysis of trends in the burden of lip and oral cavity cancer in China and worldwide. The average annual percent change (AAPC) was estimated using Joinpoint regression analysis to quantify the magnitude of temporal trends. Differences in cancer burden across age groups and sexes were evaluated, and the ARIMA model was employed to project future trends. Finally, we conducted a decomposition analysis to determine the percentage contribution of factors affecting the burden of lip and oral cancer.
From 1990 to 2021, the age-standardized incidence rate (ASIR) of lip and oral cavity cancer in China increased from 1.704 to 2.681 per 100,000 population, while the global ASIR rose from 4.270 to 4.880 per 100,000. The age-standardized prevalence rate (ASPR) in China increased from 4.168 to 10.158 per 100,000, compared to a rise from 13.888 to 17.706 per 100,000 globally. The age-standardized mortality rate (ASMR) in China declined from 1.224 to 1.152 per 100,000, while the global ASMR decreased slightly from 2.454 to 2.424 per 100,000. The age-standardized disability-adjusted life years rate (ASDR) in China fell from 32.086 to 29.205 per 100,000, whereas the global ASDR decreased from 69.266 to 67.714 per 100,000. Between 1990 and 2021, the average annual percent changes (AAPCs) in China were 1.487% for ASIR, 2.899% for ASPR, - 0.187% for ASMR, and - 0.319% for ASDR. In comparison, the corresponding global AAPCs were 0.443%, 0.796%, - 0.029%, and - 0.072%, respectively. Age and sex had a significant impact on the burden of lip and oral cavity cancer, with males consistently exhibiting higher incidence, prevalence, mortality, and DALYs than females. Projections for the next 15 years indicate that the ASIR and ASMR in China will likely stabilize, while the ASPR and ASDR are expected to continue increasing. Globally, the ASMR and ASDR are projected to remain stable, whereas the ASIR and ASPR are anticipated to rise. The decomposition analyses revealed that both population aging and population increase factors exacerbated the burden of lip and oral cancer, whereas epidemiologic changes promoted the number of lip and oral cavity cancer cases but suppressed the increase in the number of deaths and DALYs.
From 1990 to 2021, the incidence and prevalence rates of lip and oral cavity cancer increased in both China and globally, while mortality and disability-adjusted life years (DALYs) experienced a slight decline. The burden of the disease was strongly associated with sex and age, with males exhibiting significantly higher incidence, prevalence, and mortality rates than females, and older adults demonstrating substantially higher rates compared to younger age groups. Over the next 15 years, the prevalence and DALY burden in China are projected to increase, while global incidence and prevalence are also expected to rise. Given China's rapidly aging population, these findings highlight growing public health challenges that call for sustained, coordinated efforts to mitigate the future burden.
本研究旨在探讨1990年至2021年中国唇癌和口腔癌负担的时间趋势,并按年龄和性别分层。分析关键指标,包括患病率、发病率、死亡率和伤残调整生命年(DALYs),并与相应的全球指标进行比较。
利用全球疾病负担(GBD)数据库1990年至2021年的数据,我们对中国和全球唇癌和口腔癌负担的趋势进行了系统分析。使用Joinpoint回归分析估计平均年度百分比变化(AAPC),以量化时间趋势的幅度。评估不同年龄组和性别的癌症负担差异,并采用自回归积分移动平均(ARIMA)模型预测未来趋势。最后,我们进行了分解分析,以确定影响唇癌和口腔癌负担的因素的百分比贡献。
1990年至2021年,中国唇癌和口腔癌的年龄标准化发病率(ASIR)从每10万人1.704例增加到2.681例,而全球ASIR从每10万人4.270例上升到4.880例。中国的年龄标准化患病率(ASPR)从每10万人4.168例增加到10.158例,而全球则从每10万人13.888例上升到17.706例。中国的年龄标准化死亡率(ASMR)从每10万人1.224例下降到1.152例,而全球ASMR从每10万人2.454例略有下降至2.424例。中国的年龄标准化伤残调整生命年率(ASDR)从每10万人32.086例降至29.205例,而全球ASDR从每10万人69.266例降至67.714例。1990年至2021年,中国ASIR的平均年度百分比变化(AAPC)为1.487%,ASPR为2.899%,ASMR为 -0.187%,ASDR为 -0.319%。相比之下,相应的全球AAPC分别为0.443%、0.796%、 -0.029%和 -0.072%。年龄和性别对唇癌和口腔癌负担有显著影响,男性的发病率、患病率、死亡率和伤残调整生命年一直高于女性。未来15年的预测表明,中国的ASIR和ASMR可能会稳定下来,而ASPR和ASDR预计将继续上升。在全球范围内,ASMR和ASDR预计将保持稳定,而ASIR和ASPR预计将上升。分解分析表明,人口老龄化和人口增长因素都加剧了唇癌和口腔癌的负担,而流行病学变化促进了唇癌和口腔癌病例的数量,但抑制了死亡人数和伤残调整生命年的增加。
1990年至2021年,中国和全球唇癌和口腔癌的发病率和患病率均有所上升,而死亡率和伤残调整生命年(DALYs)略有下降。该疾病的负担与性别和年龄密切相关,男性的发病率、患病率和死亡率显著高于女性,老年人的发病率明显高于年轻人群体。在未来15年中,预计中国的患病率和DALY负担将增加,而全球发病率和患病率也有望上升。鉴于中国人口迅速老龄化,这些发现凸显了日益严峻的公共卫生挑战,需要持续、协调的努力来减轻未来的负担。